All lobbying filings

SL STRATEGIES, LLC

Lobbying for BAVARIAN NORDIC · Pharmaceutical company

Filing Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 22, 2025

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2026 HHS Appropriations for Project BioShield Special Reserve Fund

Health Issues

Pandemic All Hazards Preparedness Act reauthorization; Global mpox response

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.